Research Paper Volume 6, Issue 9 pp 742—754
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
Figure 2.
(A) Fasting blood glucose levels after feeding indicated diets for 2 and 4 months. (B) Fasting and glucose stimulated insulin levels in whole blood. For all, symbols represent average (± SEM) values for n=6 mice treated with (solid) or without (open) encapsulated rapamycin (eRAPA) for the indicated diet. F and p values are given for either 2 way (A) or 3 way (B) ANOVA testing indicated variables.